Article
Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication
26 Apr 2017
Abstract excerpt
Chronic hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC) and current treatments for chronic hepatitis B and HCC are suboptimal. Herein, we identified cellular serine/threonine Polo‐like‐kinase 1 (PLK1) as a positive effector of HBV replication. The aim of this study was to demonstrate the proviral role of PLK1 in HBV biosynthesis and validate PLK1 inhibition a potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
